Uptake Of Human Papilloma Virus Vaccination And Associated Factors Among Female Students Attending Secondary Schools In South West Shoa, Oromia, Ethiopia, 2022; Cros-Sectional Study

Abstract

Background; the human papilloma virus vaccine is one of the key preventative measures for cervical cancer. However, the vaccine uptake is low in resources limiting settings. The problem is particularly increasing in low and middle-income countries. Objective; to assess the uptake of human papilloma virus vaccine and associated factors among female students attending secondary schools in South West Shoa Zone, Oromia, Ethiopia, 2022. Method; A cross-sectional study was conducted in secondary schools of South West Shoa Zone in November 1 to 30, 2022. A multi-stage sampling technique was employed among 634 female students attending secondary schools. Data were collected by self-administered structured questionnaires and entered into Epi-info version 7.2.2.6 and exported to SPSS version 25 statistical packages for analysis. Descriptive statistics were used to summarize descriptive data. Variables with P-value less than 0.25 in the bivariable analysis were considered for Multivariable analysis. Adjusted Odds ratio (AOR) along with 95% confidence level was estimated to assess the strength of the association and a P value < 0.05 was considered to declare the statistical significance. Result; The proportion of Human Papillomavirus vaccine uptake was 31.65% (95% CI, 25-38). Having adequate knowledge AOR = 8.51 (95% CI =4.57-15.84), living in rural area AOR = 0.25 (95% CI =0.15-0.42), having older sister AOR = 4.07(95% =2.50-6.63), mothers‘ educational level (Diploma and above AOR = 4.08 (95% CI =1.75-9.49) and secondary education AOR =3.98 (95% CI =1.87-8.48), and fathers‘ occupation (private employee AOR =3.29 95% CI = 1.48-7.33) were significantly associated with uptake of human papilloma vaccine. Conclusion; the study revealed that; there was a very low uptake of human papilloma virus vaccine among female students attending secondary schools. All concerned bodies should work jointly to enhance the uptake of human papilloma virus vaccination among female students.